Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: biotechnology

Emergent drug gets coveted FDA status

Emergent BioSolutions Inc., of Rockville, which develops and manufactures products that harness the immune system to treat and prevent disease, announced its BioThrax treatment for anthrax disease has been granted orphan drug status by the Food and Drug Administration for people with suspected or confirmed exposure to anthrax.

Read More »

Germantown-based Intrexon agrees to acquire Medistem

Intrexon Corp., of Germantown, a developer of synthetic biological products targeting health, food, energy and environmental industries, said it has signed a definitive agreement to acquire San Diego-based Medistem Inc., a stem-cell company, in a cash-and-stock deal valued at approximately ...

Read More »

Baltimore biotech Gliknik, Pfizer sign accord

Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.

Read More »